IL60063A0 - Influenza vaccine production in liquid cell culture - Google Patents

Influenza vaccine production in liquid cell culture

Info

Publication number
IL60063A0
IL60063A0 IL60063A IL6006380A IL60063A0 IL 60063 A0 IL60063 A0 IL 60063A0 IL 60063 A IL60063 A IL 60063A IL 6006380 A IL6006380 A IL 6006380A IL 60063 A0 IL60063 A0 IL 60063A0
Authority
IL
Israel
Prior art keywords
cell culture
influenza vaccine
liquid cell
vaccine production
production
Prior art date
Application number
IL60063A
Other languages
English (en)
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL60063(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of IL60063A0 publication Critical patent/IL60063A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL60063A 1979-05-15 1980-05-13 Influenza vaccine production in liquid cell culture IL60063A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15

Publications (1)

Publication Number Publication Date
IL60063A0 true IL60063A0 (en) 1980-07-31

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60063A IL60063A0 (en) 1979-05-15 1980-05-13 Influenza vaccine production in liquid cell culture

Country Status (13)

Country Link
EP (1) EP0019218B2 (esLanguage)
JP (1) JPS55153723A (esLanguage)
AR (1) AR220838A1 (esLanguage)
AT (1) ATE16454T1 (esLanguage)
AU (1) AU535804B2 (esLanguage)
CA (1) CA1122527A (esLanguage)
DE (1) DE3071225D1 (esLanguage)
DK (1) DK154749C (esLanguage)
ES (1) ES8104405A1 (esLanguage)
IL (1) IL60063A0 (esLanguage)
NO (1) NO801443L (esLanguage)
RO (1) RO79525B (esLanguage)
YU (1) YU41923B (esLanguage)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
DK1213030T3 (da) * 1994-11-10 2009-07-20 Baxter Healthcare Sa Fremgangsmåde til fremstilling af biologiske produkter i protein-fri kultur
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
WO1996015232A1 (en) * 1994-11-16 1996-05-23 St. Jude Children's Research Hospital Novel replication process
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE10144906B4 (de) * 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
EP2923711A1 (en) 2004-11-03 2015-09-30 Novartis Vaccines and Diagnostics, Inc. Influenza vaccination
EP2022849A4 (en) * 2006-05-11 2010-10-06 Chemo Sero Therapeut Res Inst PROCESS FOR THE PROLIFERATION OF INFLUENZA VIRUS
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
WO2010092479A2 (en) 2009-02-10 2010-08-19 Novartis Ag Influenza vaccines with reduced amounts of squalene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (esLanguage) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
ES491517A0 (es) 1981-04-01
JPH0124769B2 (esLanguage) 1989-05-15
RO79525B (ro) 1984-09-30
EP0019218A2 (de) 1980-11-26
EP0019218A3 (en) 1981-03-25
AU535804B2 (en) 1984-04-05
RO79525A (ro) 1984-07-17
DK154749C (da) 1989-05-16
DK212580A (da) 1980-11-16
JPS55153723A (en) 1980-11-29
NO801443L (no) 1980-11-17
AR220838A1 (es) 1980-11-28
CA1122527A (en) 1982-04-27
YU126580A (en) 1983-12-31
ES8104405A1 (es) 1981-04-01
EP0019218B1 (de) 1985-11-13
ATE16454T1 (de) 1985-11-15
AU5824480A (en) 1980-11-20
EP0019218B2 (de) 1995-03-01
DK154749B (da) 1988-12-19
YU41923B (en) 1988-02-29
DE3071225D1 (en) 1985-12-19

Similar Documents

Publication Publication Date Title
JPS5771391A (en) Microcarrier cell culture
GB2065907B (en) Liquid crystal cells
DE3069426D1 (en) Microparticles, their preparation and their biological uses, especially in the culture of diploid cells
JPS5651981A (en) Cell cultivating method
IL60063A0 (en) Influenza vaccine production in liquid cell culture
JPS54105023A (en) Water culture unit
GB2001871B (en) Process for producing supports for cell cultures and supports so obtained
IL49795A (en) Culture bottle
IL53280A0 (en) Cell culture process
FI885436A7 (fi) Fermenttori soluviljelmien viljelemiseksi
JPS5429729A (en) Culture for shiitakeemushroom in container
GB1546691A (en) Process for the production of single cell proteins and microorganisms for use therein
AU508398B2 (en) Cell culture microcarriers
DE2964816D1 (en) Higher plant cell culture
GB2016161B (en) Coloured smectic liquid cryastal cell
DK400988A (da) Beholder til cellemassekulturer
NZ178230A (en) In vitro cultivation of vegetale cells using lactose
IT8024000A0 (it) Procedimento per immettere ossigeno in acque e recipiente per attuare il procedimento.
JPS53107955A (en) Culture container and its manufacture
GB1540579A (en) Cell culture medium
JPS5543556A (en) Display cell
JPS5638095A (en) Display cell
JPS5637288A (en) Vertical fermentation device
JPS54163884A (en) Culture medium for basidiomyces and production
JPS5424733A (en) Cultivation device utilizing culture solution